Jefferies analyst Stephen Barker downgraded Kissei Pharmaceutical to Hold from Buy with a price target of 3,400 yen, up from 3,300 yen. The analyst cites valuation for the downgrade following the recent rally in the shares.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>